FDA official logo
GSRS logo
PFDA official logo

NORGESTIMATE

  • UNII: C291HFX4DY
  • Preferred Substance Name: NORGESTIMATE

  • 35189-28-7
  • (+)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE OXIME ACETATE (ESTER)
  • 18,19-DINOR-17-PREGN-4-EN-20-YN-3-ONE, 17-(ACETYLOXY)-13-ETHYL-, OXIME, (17.ALPHA.)-(+)-
  • MIXTURE OF NORGESTIMATE (E)-AND (Z)-ISOMERS HAVING A RATIO OF (E)-TO (Z)-ISOMER BETWEEN 1.27 AND 1.78
  • NORGESTIMATE [EP MONOGRAPH]
  • NORGESTIMATE [INN]
  • NORGESTIMATE [MART.]
  • NORGESTIMATE [MI]
  • NORGESTIMATE [ORANGE BOOK]
  • NORGESTIMATE [USAN]
  • NORGESTIMATE [USP MONOGRAPH]
  • NORGESTIMATE [USP-RS]
  • NORGESTIMATE [VANDF]
  • NORGESTIMATE [WHO-DD]
  • NSC-759159
  • ORF 10131
  • ORF-10131
  • ORTHO TRI-CYCLEN COMPONENT NORGESTIMATE
  • PREFEST COMPONENT NORGESTIMATE
  • PREVIFEM COMPONENT NORGESTIMATE
  • RWJ 10131
  • RWJ-10131
  • SPRINTEC COMPONENT NORGESTIMATE
  • TRI LO SPRINTEC COMPONENT NORGESTIMATE
  • TRI-PREVIFEM COMPONENT NORGESTIMATE
  • TRI-SPRINTEC COMPONENT NORGESTIMATE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.